Originalsprog | Engelsk |
---|---|
Tidsskrift | Arthritis & Rheumatism |
ISSN | 0004-3591 |
DOI | |
Status | Udgivet - 2012 |
First in patient study of anti-GM-CSF monoclonal antibody (MOR103) in active rheumatoid arthritis: Results of a phase 1b/2a randomized, double-blind, placebo-controlled trial.
F. Behrens, Mikkel Østergaard, R. Stoilov, P. Wiland, T.W. Huizinga, V.Y. Berenfus, P.-P. Tak, S. Vladeva, J. Rech, A. Rubbert-Roth, M. Korkosz, D. Rekalov, I.A. Zupanets, B.J. Ejbjerg, J. Geiseler, J. Fresenius, R.P. Korolkiewicz, A.J. Schottelius, H. Burkhardt
Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning › peer review